Basel Medical Group Ltd - ordinary shares (BMGL)
Healthcare › Services-Offices & Clinics of Doctors of Medicine
Price History
Feb 9, 2026 — Mar 25, 2026Investment Snapshot
- P/B of 3.14 — trading above book value
- Piotroski F-Score 1/9 — signs of financial weakness
- Loss-making — negative ROE of -248.5%
Basel Medical Group Ltd - ordinary shares (BMGL) is a Healthcare company operating in Services-Offices & Clinics of Doctors of Medicine, listed on the NASDAQ , with a market capitalisation of $12 million . Key value metrics: P/B ratio 3.14, Piotroski F-Score 1 out of 9 .
Value Score
Key Metrics
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Basel Medical Group Ltd - ordinary shares — Fundamental Analysis Summary
On financial health, BMGL shows a weak Piotroski F-Score of 1/9, a signal of deteriorating financial health, and negative return on equity of -248.5% (sector average: -19.8%), and high leverage with a debt-to-equity ratio of 2.46.
StockPik's composite Value Score for BMGL is 35/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.